Matrix interference, method suitability, and the complexity of biologics are driving more careful approaches to endotoxin testing and control. Reliable bacterial endotoxin testing requires more than a sensitive assay. Matrix...
EMBOCAPS® is excited to be part of SupplySide Global 2026 at Mandalay Bay — one of the nutraceutical industry's most dynamic and fast-moving events. This year, we're bringing our full...
Curia Global, Inc. (Curia), a leading global contract development and manufacturing organisation (CDMO), announced a strategic investment to expand its sterile API manufacturing capabilities for both steroid and non-steroid products...
Anton Paar introduces the new UNHT Series, a new generation of nanoindentation systems designed to deliver reliable results, faster workflows, and greater versatility across a wide range of materials. At...
Curia, a leading contract development and manufacturing organisation (CDMO), announced the approval of three additional active pharmaceutical ingredients (APIs) in China: Loteprednol Etabonate, Bromocriptine, and Betamethasone-21-Phosphate Disodium Salt. These approvals...
CEO Simon Michel provides an update on Ypsomed's (SIX: YPSN) first quarter of fiscal year 2026/27. Thanks to new customer projects spanning many therapeutic areas, international recognition for its innovation,...
Ypsomed and ten23 health announced the next milestone in their strategic partnership for the YpsoDose wearable injector. By installing dedicated device assembly capabilities for Ypsomed's large-volume wearable injector, ten23 health is further...
Ypsomed has been honoured with the renowned Red Dot Award in the Product Design category for its new YpsoLoop autoinjector platform. YpsoLoop combines recyclability with user-friendliness in an innovative platform...
Proprietary algorithm optimised tablet composition and dose level for clinical study in healthy participants Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organisation), reported interim results from...
New AI-enhanced solution helps identify promising drug formulations, compressing early clinical decision-making for new treatments Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organisation), and Acesion Pharma,...
